Invasive Aspergillosis Due to Aspergillus Section Usti: A Multicenter Retrospective Study.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Emmanouil GlampedakisFrederic Lamoth

Abstract

Aspergillus spp. of section Usti (A. ustus) represent a rare cause of invasive aspergillosis (IA). This multicenter study describes the epidemiology and outcome of A. ustus infections. Patients with A. ustus isolated from any clinical specimen were retrospectively identified in 22 hospitals from 8 countries. When available, isolates were sent for species identification (BenA/CaM sequencing) and antifungal susceptibility testing. Additional cases were identified by review of the literature. Cases were classified as proven/probable IA or no infection, according to standard international criteria. Clinical report forms were obtained for 90 patients, of whom 27 had proven/probable IA. An additional 45 cases were identified from literature review for a total of 72 cases of proven/probable IA. Hematopoietic cell and solid-organ transplant recipients accounted for 47% and 33% cases, respectively. Only 8% patients were neutropenic at time of diagnosis. Ongoing antimold prophylaxis was present in 47% of cases. Pulmonary IA represented 67% of cases. Primary or secondary extrapulmonary sites of infection were observed in 46% of cases, with skin being affected in 28% of cases. Multiple antifungal drugs were used (consecutively or in combin...Continue Reading

References

Sep 1, 1983·American Journal of Clinical Pathology·L M Weiss, W A Thiemke
Feb 1, 1995·Journal of Clinical Microbiology·M G FakihC S Berenson
Aug 1, 1994·Journal of the American Academy of Dermatology·M J StillerM A Gordon
May 20, 1998·Journal of the American Academy of Dermatology·R M RicciL C Sadkowski
Apr 16, 1999·Journal of Clinical Microbiology·P E VerweijJ F Meis
Apr 17, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J W BaddleyP G Pappas
Sep 10, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alexander ImhofKieren A Marr
May 18, 2006·Emerging Infectious Diseases·Anil A PanackalKieren A Marr
Jan 12, 2008·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Parsia A VagefiCamille N Kotton
May 9, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ben De PauwUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Jul 22, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brahm H SegalBen E De Pauw
Oct 10, 2008·Diagnostic Microbiology and Infectious Disease·Suganthini Krishnan-NatesanSanjay G Revankar
Jul 2, 2009·Hand : Official Journal of the American Association for Hand Surgery·Olushola OlorunnipaCatherine M Curtin
Aug 28, 2009·Journal of Clinical Microbiology·Deanna A SuttonMarc G Schecter
Mar 12, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasTom M Chiller
Mar 12, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dimitrios P KontoyiannisPeter G Pappas
Jun 15, 2010·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Miguel M CabadaVincent G Valentine
Sep 6, 2011·Studies in Mycology·R A SamsonJ C Frisvad
Aug 18, 2012·The Journal of Infection·William J SteinbachDavid L Horn
Jun 29, 2014·Mycopathologia·Ana Alastruey-IzquierdoManuel Cuenca-Estrella
Dec 11, 2014·Studies in Mycology·R A SamsonJ C Frisvad
Oct 28, 2015·Texas Heart Institute Journal·Magdy M El-Sayed AhmedO H Frazier
Feb 16, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Frederic LamothBarbara D Alexander
Jul 26, 2017·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Justin SeroyNina M Clark
Mar 17, 2018·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A J UllmannO A Cornely
Dec 14, 2018·BMC Infectious Diseases·Nawel Aït-AmmarFrançoise Botterel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.